Surviving Lymphoma: Secondary Cancers

Secondary cancers are cancers that develop as a result of chemotherapy and/or radiotherapy. These cancers are usually unrelated to the first disease a patient suffered from. Rather, they are a long-term side effect of the treatment used to combat the original cancer.

These side-effects can occur months or years after a patient enters remission. The use of strong chemotherapy agents like etoposide, high doses of radiation, or combination chemo and radiation therapy all increase a patient's risk of developing a secondary cancer.

Lymphoma Treatment Center

Insurance Accepted.
Innovative Lymphoma Treatments.
Call 415-343-6162 Today

Due to this possibility, cancer survivors are monitored closely by their doctors. That way, if a secondary cancer does arise, it will be caught early when it is treatable.

Hodgkin's Lymphoma

For Hodkgin's Lymphoma, the most common secondary cancers are:

  • Stomach cancer
  • Lung cancer
  • Colorectal cancer
  • Thyroid cancer
  • Breast cancer
  • Bone cancer
  • Leukemia
  • Non-Hodgkin Lymphoma

The chance for developing a secondary cancer after 20 years of remission is 10%. This risk increases to 26% after 30 years. Patients who were younger than 21 years of age during their treatment have a higher incidence of secondary cancers, and that risk increases if both chemotherapy and radiation were used.

Non-Hodgkin's Lymphoma (NHL)

The most common secondary cancers after treatment for Non-Hodgkin's Lymphomas are:

  • Leukemia
  • Other Non-Hodgkin's Lymphomas

The incidence rates for secondary cancers are usually lower when compared to Hodgkin's patients. However, these statistics change based on the type of NHL and the treatment used.

Photo: Pexels

Lymphoma Treatment Center

Insurance Accepted.
Innovative Lymphoma Treatments.
Call 415-343-6162 Today

More Articles

More Articles

This entry looks at Non Hodgkin's Lymphoma in the lungs, clinically known as pulmonary lymphoma, one of the subtypes of lymphoma. 'Lymphoma' is an...

In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

The Erythrocyte Sedimentation Rate (ESR - sometimes called sed rate or sedimentation rate) is a nonspecific screening test for various...

Blood counts can be used to identify disease and monitor patient health during cancer treatments. Though these tests cannot diagnose lymphoma on...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...